STAg-derived cyclophilin (C-18) inhibits infectivity of HIV-1 R5 strains
Virus . | Clade . | Coreceptor . | Target cell . | ID50, μg/mL . |
---|---|---|---|---|
JR-CSF | B (US) | CCR5 | PM1 | 0.4 |
Ba-L | B (US) | CCR5 | PM1 | 3.8 |
92US657 | B (US) | CCR5 | PBMC | 2.1 |
92BR003 | B (Brazil) | CCR5 | PBMC | 2.7 |
92BR017 | B (Brazil) | CCR5 | PBMC | 4.0 |
92BR007 | C (Brazil) | CCR5 | PBMC | 14.0 |
98CN009 | C (China) | CCR5 | PBMC | 3.3 |
98IN017 | C (India) | CXCR4 | PBMC | No inhibitor |
Virus . | Clade . | Coreceptor . | Target cell . | ID50, μg/mL . |
---|---|---|---|---|
JR-CSF | B (US) | CCR5 | PM1 | 0.4 |
Ba-L | B (US) | CCR5 | PM1 | 3.8 |
92US657 | B (US) | CCR5 | PBMC | 2.1 |
92BR003 | B (Brazil) | CCR5 | PBMC | 2.7 |
92BR017 | B (Brazil) | CCR5 | PBMC | 4.0 |
92BR007 | C (Brazil) | CCR5 | PBMC | 14.0 |
98CN009 | C (China) | CCR5 | PBMC | 3.3 |
98IN017 | C (India) | CXCR4 | PBMC | No inhibitor |
PM1 cells were infected with the R5 virus (BA-L, JR-CSF) (100 TCID50 per well). PBMCs were stimulated with PHA-P (0.25 μg/mL) and IL-2 (20 U/mL) for 3 days and were then infected with primary isolates (100 TCID50 per well). C-18 protein (at serial 3-fold dilutions) was preincubated with the cells for one hour at 37°C before addition of the virus (5 replicate per group). The virus was washed away after 2 days. Supematants were collected every 2 days and assayed for p24 activity. The 50% viral inhibition dose was calculated according to Reed and Muench as described by Shibata et al. 16 No inhibition was observed with human cyclophilin.